skip to main content

Yellow Card reporting — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyAdverse Drug Reactions and Drug SafetyYellow Card reportingGPhC CRA

A patient develops a widespread rash after starting lamotrigine 2 weeks ago. The prescriber has stopped the medicine and asks whether the pharmacy should report it. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Submit a Yellow Card report because a serious suspected adverse reaction is possible

The Yellow Card Scheme is used for suspected adverse drug reactions, especially serious reactions or reactions to newer medicines. Proof of causality is not required before reporting. Lamotrigine rash can be clinically significant and may require urgent assessment. Pharmacy documentation should complement, not replace, reporting.

Reference: MHRA Yellow Card Scheme; GPhC Standards